Thomas Templeman, Chief Technology Officer at Centessa Pharmaceuticals plc (CNTA), bought 250 shares at $20.00 ($5K) on 2021-06-02, disclosed to the SEC on 2021-06-04.
Open-market purchase of $5k CNTA by Chief Technology Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.